Wally, Verena http://orcid.org/0000-0001-8705-3890
Reisenberger, Manuela
Kitzmüller, Sophie
Laimer, Martin
Funding for this research was provided by:
DEBRA Austria
Article History
Received: 26 May 2020
Accepted: 21 July 2020
First Online: 19 October 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Verena Wally holds shares of the company Diaderm, which receives license payments from Castle Creek Biosciences (CCB). CCB conducts studies with a diacerein-containing ointment.Martin Laimer: Grant/Research/Clinical Trial Support: Bristol-Myers Squibb (Squamous cell carcinoma); Onconova Therapeutics; Amryt Pharma; Rehacell; Holostem Terapie Avanzate; Castle Creek Biosciences (Epidermolysis bullosa).